Skip to main content

Table 2 Best tumor response and overall response rate (ORR) by disease site (n = 29)

From: Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

Best tumor response No. %
Complete response 2 6.9
Partial response 14 48.3
Overall response rate 16 55.2 (CI 37.5–62.5)
No change 10 34.5
Progressive disease 3 10.3
ORR by disease site   
   Breast (locally advanced) 9/12 75.0
   Viscera 9/13 69.2
   Liver 3/11 27.3
   Lymph node 6/6 100
  1. ORR, overall response rate